GCSLX
Price
$26.09
Change
+$0.26 (+1.01%)
Updated
Sep 11 closing price
Net Assets
917.73M
VGPMX
Price
$24.32
Change
+$0.05 (+0.21%)
Updated
Sep 11 closing price
Net Assets
3.94B
Interact to see
Advertisement

GCSLX vs VGPMX

GCSLX vs VGPMX Comparison Chart in %
View a ticker or compare two or three
VS
GCSLX vs. VGPMX commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GCSLX is a Buy and VGPMX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VGPMX has more cash in the bank: 3.94B vs. GCSLX (918M). VGPMX pays higher dividends than GCSLX: VGPMX (3.19) vs GCSLX (1.02). GCSLX was incepted earlier than VGPMX: GCSLX (21 years) vs VGPMX (42 years). GCSLX (1.89) is less costly to investors than VGPMX (0.42). GCSLX is a more actively managed with annual turnover of: 68.00 vs. VGPMX (50.00). GCSLX has a lower initial minimum investment than VGPMX: GCSLX (2500) vs VGPMX (3000). VGPMX annual gain was more profitable for investors over the last year : 38.91 vs. GCSLX (14.27). VGPMX return over 5 years is better than : 128.35 vs. GCSLX (33.93).
GCSLXVGPMXGCSLX / VGPMX
Total Expense Ratio1.850.42440%
Annual Report Gross Expense Ratio1.890.42450%
Fund Existence21 years42 years-
Gain YTD16.71919.31087%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets918M3.94B23%
Annual Yield % from dividends1.023.1932%
Returns for 1 year14.2738.9137%
Returns for 3 years63.43104.6461%
Returns for 5 years33.93128.3526%
Returns for 10 years111.90129.4886%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CRL278.265.26
+1.93%
Charles River Laboratories International
TATT38.460.61
+1.61%
TAT Technologies Ltd
WAFD33.88-0.22
-0.65%
WaFd
PMVP1.40-0.04
-2.78%
PMV Pharmaceuticals
UK1.96-0.06
-2.97%
Ucommune International Ltd.